Global Fund’s new HIV and TB multicountry grants in Eastern Europe and Central Asia begin implementation
The Global Fund Board has recently approved several multicountry grants, whose aim is to address priorities “deemed critical to fulfil the aims of the Global Fund 2017-2022 strategy,” and to address needs that are not being fulfilled by national (single country) allocations.
Among the grants approved by the Global Fund Board on 21 December 2018 (see GFO article) were three multi-country grants. Two of the grants were for Eastern Europe and Central Asia (EECA); the third was for West and Central Africa. (See table.)
On 13-14 November 2017, a consultation took place in Minsk, Belarus, co-organized by the Eastern Europe and Central Asia (EECA) team at the Global Fund Secretariat and the UNAIDS Regional Office for EECA, to discuss with regional stakeholders the terms of reference (TOR) for next round of multi-country HIV projects for the EECA region to be financed by the Global Fund.
Georgia has developed a transition plan in response to gradual reductions over the years to its allocations from the Global Fund. The goal of the Georgia Transition Plan is to ensure a smooth transitioning to full domestic funding of the HIV and TB programs by 2022 without compromising services. However, the plan does not specify which services the government is taking over or when.
How the Global Fund’s policy on CCM composition helped to boost LGBT participation in decision-making in the EECA
Global Fund policies on the composition of country coordinating mechanisms (CCMs) have resulted in increased participation of LGBT organizations on CCMs in Eastern Europe and Central Asia (EECA). It has also resulted in greater participation of LGBT representatives in the decisions of the CCMs and even of the governments in these countries, including decisions concerning prevention services.
Kyrgyzstan’s program continuation funding request to the Global Fund provides little information on the proposed program
There is little information in the TB/HIV funding request submitted by the Kyrgyzstan country coordinating mechanism (CCM) on the program that the applicant proposes to implement. And there is almost no information on how Kyrgyzstan plans to cope with an allocation that is significantly lower than what it received for 2014-2016.
A new database is being developed in Eastern Europe and Central Asia (EECA) containing information on antiretrovirals (ARVs) in use in 15 countries: Armenia, Azerbaijan, Belarus, Estonia, Georgia, Kazakhstan, Kyrgyzstan, Latvia, Lithuania, Moldova, Poland, the Russian Federation, Tajikistan, Ukraine and Uzbekistan.
A regional program in Eastern Europe and Central Asia (EECA) will pilot an innovative city service model to combat HIV and TB, with a special focus on key affected populations (KAPs).
In the allocation letters to countries in Eastern Europe and Central Asia (EECA), the Global Fund made a strong push for increasing investments in building resilient and sustainable systems for health (RSSH).